Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records.

Brownstein JS, Murphy SN, Goldfine AB, Grant RW, Sordo M, Gainer V, Colecchi JA, Dubey A, Nathan DM, Glaser JP, Kohane IS.

Diabetes Care. 2010 Mar;33(3):526-31. doi: 10.2337/dc09-1506. Epub 2009 Dec 15.

2.

Rosiglitazone and myocardial infarction in patients previously prescribed metformin.

Dormuth CR, Maclure M, Carney G, Schneeweiss S, Bassett K, Wright JM.

PLoS One. 2009 Jun 27;4(6):e6080. doi: 10.1371/journal.pone.0006080. Erratum in: PLoS One. 2010;5(7). doi: 10.1371/annotation/3330720e-5520-4211-91f3-d3b3d20e9804.

3.

Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.

Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, Radican L.

Curr Med Res Opin. 2010 Jul;26(7):1697-703. doi: 10.1185/03007995.2010.489029.

PMID:
20465367
4.

Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.

Ahuja V, Sohn MW, Birge JR, Syverson C, Budiman-Mak E, Emanuele N, Cooper JM, Huang ES.

J Manag Care Spec Pharm. 2015 Dec;21(12):1214-34.

6.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.

PMID:
18036392
7.

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Johnson JA, Majumdar SR, Simpson SH, Toth EL.

Diabetes Care. 2002 Dec;25(12):2244-8.

PMID:
12453968
8.

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.

PMID:
16443869
9.

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA.

Circulation. 2004 Sep 21;110(12):1572-8. Epub 2004 Sep 13.

10.
11.

Postmenopausal estrogens and risk of myocardial infarction in diabetic women.

Kaplan RC, Heckbert SR, Weiss NS, Wahl PW, Smith NL, Newton KM, Psaty BM.

Diabetes Care. 1998 Jul;21(7):1117-21.

PMID:
9653605
12.

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID:
16861090
13.

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment.

Davis TM, Parsons RW, Broadhurst RJ, Hobbs MS, Jamrozik K.

Diabetes Care. 1998 Apr;21(4):637-40.

PMID:
9571356
14.

Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.

Walker AM, Koro CE, Landon J.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):760-8. doi: 10.1002/pds.1598.

PMID:
18383443
15.
16.

Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin.

Marceille JR, Goins JA, Soni R, Biery JC, Lee TA.

Pharmacotherapy. 2004 Oct;24(10):1317-22.

PMID:
15628829
18.

Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality.

Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR.

Cardiol Rev. 2005 Sep-Oct;13(5):223-30.

PMID:
16106183
19.

Medical therapy for diabetes is associated with increased use of lower endoscopy.

Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP Jr, Habel LA.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1195-202.

PMID:
17603822
20.

Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study.

Donnan PT, Boyle DI, Broomhall J, Hunter K, MacDonald TM, Newton RW, Morris AD.

Diabet Med. 2002 Jun;19(6):448-55.

PMID:
12060055

Supplemental Content

Support Center